In SURMOUNT-1, tirzepatide showed mean losses that reached about 20.9% at 72 weeks at the highest dose studied
Trompier D, Chang XB, Barattin R, du Moulinet DHardemare A, Di Pietro A, Baubichon-Cortay H
Discover Personalized Care with Doctronic Ready to take the next step in managing your metabolic health with the innovative combination of GLP1 therapies and probiotics
The team emphasizes that despite these differences, both medications require gradual dose escalation, consistent adherence, and lifestyle changes for best results
If you notice these changes, skip that site for two weeks and switch to a different abdominal location
What happens to our muscles when we discontinue GLP-1s after weight loss